KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Cvs Health's Depreciation & Amortization (CF) changed 0.0% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.6 billion, marking a year-over-year increase of 19.58%. This contributed to the annual value of $4.6 billion for FY2025, which is 19.58% up from last year.
  • Latest data reveals that Cvs Health reported Depreciation & Amortization (CF) of $1.1 billion as of Q4 2025, which was down 0.0% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Depreciation & Amortization (CF) ranged from a high of $1.2 billion in Q2 2025 and a low of $1.0 billion during Q1 2023
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $1.1 billion (2021), whereas its average is $1.1 billion.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 740.74% in 2022, then skyrocketed by 1368.63% in 2024.
  • Quarter analysis of 5 years shows Cvs Health's Depreciation & Amortization (CF) stood at $1.1 billion in 2021, then decreased by 4.22% to $1.0 billion in 2022, then increased by 8.72% to $1.1 billion in 2023, then increased by 1.15% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.1 billion for Q3 2025, and $1.2 billion during Q2 2025.